Accéder au contenu
Merck

Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice.

Drug metabolism reviews (2007-09-06)
Volker Mostert, Akihiro Nakayama, Lori M Austin, Ximena A Levander, Christopher D Ferris, Kristina E Hill, Raymond F Burk
RÉSUMÉ

Heme oxygenase (HO)-1 is induced by oxidative stress and protects against oxidant injury. We examined the effect of rapid induction of hepatic HO-1 on serum iron level. Serum iron was approximately doubled within 6 h when HO-1 was induced by phenobarbital treatment of selenium-deficient mice. Blocking heme synthesis with diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate (DDC) prevented the induction of HO-1 and the rise in serum iron. DDC did not block HO-1 induction by hemin. Inhibition of HO activity by tin protoporphyrin prevented a rise in serum iron that occurred following phorone treatment. These results indicate that heme synthesis or an exogenous source of heme is needed to allow induction of HO-1. Further, they link HO-1 induction with a rise in serum iron, suggesting that the iron resulting from catabolism of heme by HO-1 is released by the liver.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate, 99%